Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials.
about
Gastric cancer: Current status of lymph node dissectionSerum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.Adjuvant therapy for gastric cancer: current and future directions.A meta-analysis of D1 versus D2 lymph node dissection.Surgical interventions for gastric cancer: a review of systematic reviews.Accomplishments in 2008 in the management of localized gastric cancerQuality of care indicators for the surgical treatment of gastric cancer: a systematic review.Lymph node dissection for gastric cancer: a critical review.HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine.High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.Is There Any Role for D3 Lymphadenectomy in Gastric Cancer?
P2860
Q26766091-34D4B929-E0CF-48F4-B01D-FA7264C3F9D2Q33879899-B056FCF5-02A0-4F56-A9BA-1B19D462077EQ34255463-B4372669-5025-49D8-BEB4-2F5B24E8ABF6Q34326579-D3940331-F1C4-4A31-9964-C561F180BA2DQ34634079-B5704A66-654F-486A-B7B3-2C84490C212BQ35835828-5A2B0172-8FED-4443-9456-3497EC08E106Q37468843-88203720-73A8-4571-BDCA-2AA6A7CF8755Q38051100-DF1C9F15-09A0-4413-B8FB-77177374205CQ38493106-1E79E71F-11D9-4112-9150-FF0663FDD208Q38829125-A8610CA6-C18C-4F60-A0F6-808D2B5A6F63Q38831415-8C21F8AE-93DE-40C6-BD00-A59B9D987E71Q40614622-557D3416-6EC7-4368-92D2-AB71DAA50D5CQ46106512-CE748CD1-9083-4C87-87F8-01C00EBDCB2CQ50930365-3CC2E26F-9336-4CB1-AC62-37AE5337B1BFQ53247758-4C8AB039-CA0A-4BFA-9025-87F10E85226CQ55035405-2876B860-3448-40BB-9412-5E4A88425968
P2860
Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Impact of extended lymphadenec ...... of randomized clinical trials.
@en
Impact of extended lymphadenec ...... of randomized clinical trials.
@nl
type
label
Impact of extended lymphadenec ...... of randomized clinical trials.
@en
Impact of extended lymphadenec ...... of randomized clinical trials.
@nl
prefLabel
Impact of extended lymphadenec ...... of randomized clinical trials.
@en
Impact of extended lymphadenec ...... of randomized clinical trials.
@nl
P2093
P2860
P921
P1476
Impact of extended lymphadenec ...... of randomized clinical trials.
@en
P2093
Alvaro Nagib Atallah
Delcio Matos
Gaspar de Jesus Lopes Filho
Humberto Saconato
Suzana Angélica Silva Lustosa
P2860
P304
P356
10.1590/S0102-86502008000600009
P577
2008-11-01T00:00:00Z